Sex‐Stratified Long‐Term Outcome After Percutaneous Coronary Intervention: A Pooled Analysis of the SORT OUT All‐Comer Trials
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.039758 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Emil N Holck und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Aarhus University Hospital Aarhus N Denmark. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Coronary Artery Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Currently, the sex‐differentiated outcome after percutaneous coronary intervention (PCI) favors male sex in most studies. In this study, we aimed to investigate the age‐adjusted impact of sex on long‐term outcome.
Methods
The study was an observational, prospective, multicenter, cohort study with pooling of 5‐year results of the randomized controlled all‐comer stent trials SORT OUT (Scandinavian Organization for Randomized Trials With Clinical Outcome) III, V, VI, VII, VIII, and IX conducted from 2006 to 2017. All patients were followed for 5 years. The predefined main outcome was a major adverse cardiac event (MACE); a composite end point comprising all‐cause death, spontaneous myocardial infarction, and target lesion revascularization assessed by a clinical event committee. MACE difference across sex was assessed by incidence rate ratios at 5 years adjusted for age and predefined risk factors.
Results
In total, 15 242 patients (women, 3729 [24.5%]) with a mean age of 67.8±11.0 years were included in the study, with 0.2% lost to follow‐up. Compared with men, women were older (women, 67.8±11.0 years; men, 64.8±10.7 years), had more hypertension and dyslipidemia but less previous MI and revascularization. MACEs occurred in 747 (21.8%) of the women and 2196 (20.5%) of the men at 5 years (unadjusted incidence rate ratio, 1.07 [95% CI, 0.98–1.16]; and adjusted incidence rate ratio, 0.91 [95% CI, 0.84–0.99]). Female sex was not associated with an increased risk in any of the individual MACE components.
Conclusions
Female sex was not associated with a poorer long‐term outcome than male sex after treatment for coronary artery disease with percutaneous coronary intervention in MACEs or any of the individual components.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology Aarhus University Hospital Aarhus N Denmark.
- Department of Clinical Medicine, Health Aarhus University Aarhus N Denmark.
- Department of Cardiology Aalborg University Hospital Aalborg Denmark.
- Department of Clinical Epidemiology Aarhus University Hospital Aarhus N Denmark.
- Department of Cardiology Odense University Hospital Odense C Denmark.
- Department Of Clinical Research University of Southern Denmark Odense M Denmark.
ORCID-Profile: Emil N Holck, Jelmer Westra, Lars Jakobsen, Ashkan Eftekhari, Jens F Lassen, Lisette O Jensen, Evald H Christiansen
Zitieren
APA
Holck, E. N., Westra, J., Jakobsen, L., Eftekhari, A., Freeman, P., Kahlert, J., Lassen, J. F., Jensen, L. O., & Christiansen, E. H. (2025). Sex‐Stratified Long‐Term Outcome After Percutaneous Coronary Intervention: A Pooled Analysis of the SORT OUT All‐Comer Trials. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.039758
Vancouver
Holck EN, Westra J, Jakobsen L, Eftekhari A, Freeman P, Kahlert J, et al. Sex‐Stratified Long‐Term Outcome After Percutaneous Coronary Intervention: A Pooled Analysis of the SORT OUT All‐Comer Trials. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.039758
BibTeX
@article{Holck2025,
author = {Holck, Emil N and Westra, Jelmer and Jakobsen, Lars and Eftekhari, Ashkan and Freeman, Phillip and Kahlert, Johnny and Lassen, Jens F and Jensen, Lisette O and Christiansen, Evald H},
title = {Sex‐Stratified Long‐Term Outcome After Percutaneous Coronary Intervention: A Pooled Analysis of the SORT OUT All‐Comer Trials},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.039758}
}
EUVIMED